HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.

Abstract
Autosomal-dominant centronuclear myopathy (CNM) due to mutations in the dynamin 2 gene (DNM2) is a rare congenital myopathy histopathologically characterized by centrally located nuclei and a radial arrangement of sarcoplasmic strands around the central nuclei. A total of 1,582 consecutive muscle biopsies of adult patients (age ≥ 18 years) were screened for morphologically characteristic signs of CNM. Patients with CNM were screened for mutations in DNM2. Clinical data and complementary neurophysiologic, respiratory, cardiac, and muscle MRI data in these patients were analyzed. Six index patients had histopathological signs of CNM (0.38%). Three had the heterozygous p.R465W and 2 siblings the heterozygous p.E368K DNM2 mutation. In 2 patients mutational screening for DNM2, BIN1, MTM1, and RYR1 was negative. Apart from the siblings, there was no positive history, parental mutation screening in 2 cases was negative. Both the percentage of muscle fibers with centralized nuclei and the ratio of muscle fibers with centralized to internalized nuclei were higher in DNM2-CNM compared to non-DNM2-CNM (50% vs. 18% and 94% vs. 63%). The onset was already neonatal or in infancy in 3/5 patients with DNM2 mutation. Symptoms in DNM2-CNM included bilateral ptosis (n = 3), paresis of the external ocular muscles (n = 2), axonal neuropathy (n = 4), restrictive ventilatory involvement (n = 5), and contractures (n = 5), including muscular torticollis (n = 1) and masticatory muscles (n = 2). DNM2-CNM patients and non-DNM2-CNM patients could not be distinguished by clinical features. DNM2-CNM often shows de novo mutations. In addition to the feature of radial sarcoplasmic strands, the ratio of centrally to internalized nuclei might help to differentiate DNM2-CNM from other forms of CNM. Other genes than currently known seem to cause the clinical and histopathological phenotype of CNM.
AuthorsF Hanisch, T Müller, A Dietz, M Bitoun, W Kress, J Weis, G Stoltenburg, S Zierz
JournalJournal of neurology (J Neurol) Vol. 258 Issue 6 Pg. 1085-90 (Jun 2011) ISSN: 1432-1459 [Electronic] Germany
PMID21221624 (Publication Type: Journal Article)
Chemical References
  • Dynamin II
Topics
  • Action Potentials (genetics)
  • Adult
  • Aged
  • DNA Mutational Analysis (methods)
  • Dynamin II (genetics)
  • Female
  • Heart Diseases (etiology)
  • Humans
  • Male
  • Middle Aged
  • Muscle, Skeletal (pathology, ultrastructure)
  • Mutation (genetics)
  • Myopathies, Structural, Congenital (complications, genetics, pathology)
  • Neural Conduction (genetics)
  • Peripheral Nerves (physiopathology)
  • Phenotype
  • Respiration Disorders (etiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: